175 related articles for article (PubMed ID: 28942573)
1. Berberine Inhibits Oxygen Consumption Rate Independent of Alteration in Cardiolipin Levels in H9c2 Cells.
Chang W; Zhang M; Chen L; Hatch GM
Lipids; 2017 Nov; 52(11):961-967. PubMed ID: 28942573
[TBL] [Abstract][Full Text] [Related]
2. Berberine treatment attenuates the palmitate-mediated inhibition of glucose uptake and consumption through increased 1,2,3-triacyl-sn-glycerol synthesis and accumulation in H9c2 cardiomyocytes.
Chang W; Chen L; Hatch GM
Biochim Biophys Acta; 2016 Apr; 1861(4):352-62. PubMed ID: 26774040
[TBL] [Abstract][Full Text] [Related]
3. Berberine improves insulin resistance in cardiomyocytes via activation of 5'-adenosine monophosphate-activated protein kinase.
Chang W; Zhang M; Li J; Meng Z; Wei S; Du H; Chen L; Hatch GM
Metabolism; 2013 Aug; 62(8):1159-67. PubMed ID: 23537779
[TBL] [Abstract][Full Text] [Related]
4. Amorphous solid dispersion of Berberine mitigates apoptosis via iPLA
Li J; Du H; Zhang M; Zhang Z; Teng F; Zhao Y; Zhang W; Yu Y; Feng L; Cui X; Zhang M; Lu T; Guan F; Chen L
Int J Biol Sci; 2019; 15(7):1533-1545. PubMed ID: 31337982
[No Abstract] [Full Text] [Related]
5. Berberine Pretreatment Confers Cardioprotection Against Ischemia-Reperfusion Injury in a Rat Model of Type 2 Diabetes.
Chang W; Li K; Guan F; Yao F; Yu Y; Zhang M; Hatch GM; Chen L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):486-94. PubMed ID: 26846272
[TBL] [Abstract][Full Text] [Related]
6. Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression.
Kong WJ; Zhang H; Song DQ; Xue R; Zhao W; Wei J; Wang YM; Shan N; Zhou ZX; Yang P; You XF; Li ZR; Si SY; Zhao LX; Pan HN; Jiang JD
Metabolism; 2009 Jan; 58(1):109-19. PubMed ID: 19059538
[TBL] [Abstract][Full Text] [Related]
7. Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5'-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells.
Chang W; Zhang M; Meng Z; Yu Y; Yao F; Hatch GM; Chen L
Eur J Pharmacol; 2015 Dec; 769():55-63. PubMed ID: 26522928
[TBL] [Abstract][Full Text] [Related]
8. Berberine alleviates hepatic lipid accumulation by increasing ABCA1 through the protein kinase C δ pathway.
Liang H; Wang Y
Biochem Biophys Res Commun; 2018 Apr; 498(3):473-480. PubMed ID: 29505790
[TBL] [Abstract][Full Text] [Related]
9. Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly.
Mejia EM; Chau S; Sparagna GC; Sipione S; Hatch GM
Lipids; 2016 May; 51(5):561-9. PubMed ID: 26846325
[TBL] [Abstract][Full Text] [Related]
10. Berberine, a plant alkaloid with lipid- and glucose-lowering properties: From in vitro evidence to clinical studies.
Pirillo A; Catapano AL
Atherosclerosis; 2015 Dec; 243(2):449-61. PubMed ID: 26520899
[TBL] [Abstract][Full Text] [Related]
11. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression.
Zhang H; Wei J; Xue R; Wu JD; Zhao W; Wang ZZ; Wang SK; Zhou ZX; Song DQ; Wang YM; Pan HN; Kong WJ; Jiang JD
Metabolism; 2010 Feb; 59(2):285-92. PubMed ID: 19800084
[TBL] [Abstract][Full Text] [Related]
12. Berberine elevates cardiolipin in heart of offspring from mouse dams with high fat diet-induced gestational diabetes mellitus.
Cole LK; Sparagna GC; Vandel M; Xiang B; Dolinsky VW; Hatch GM
Sci Rep; 2021 Aug; 11(1):15770. PubMed ID: 34349203
[TBL] [Abstract][Full Text] [Related]
13. Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease.
Zhao L; Cang Z; Sun H; Nie X; Wang N; Lu Y
BMC Endocr Disord; 2017 Feb; 17(1):13. PubMed ID: 28241817
[TBL] [Abstract][Full Text] [Related]
14. Berberine improves free-fatty-acid-induced insulin resistance in L6 myotubes through inhibiting peroxisome proliferator-activated receptor gamma and fatty acid transferase expressions.
Chen Y; Li Y; Wang Y; Wen Y; Sun C
Metabolism; 2009 Dec; 58(12):1694-702. PubMed ID: 19767038
[TBL] [Abstract][Full Text] [Related]
15. Berberine, a natural antidiabetes drug, attenuates glucose neurotoxicity and promotes Nrf2-related neurite outgrowth.
Hsu YY; Tseng YT; Lo YC
Toxicol Appl Pharmacol; 2013 Nov; 272(3):787-96. PubMed ID: 23954465
[TBL] [Abstract][Full Text] [Related]
16. Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action.
Turner N; Li JY; Gosby A; To SW; Cheng Z; Miyoshi H; Taketo MM; Cooney GJ; Kraegen EW; James DE; Hu LH; Li J; Ye JM
Diabetes; 2008 May; 57(5):1414-8. PubMed ID: 18285556
[TBL] [Abstract][Full Text] [Related]
17. Berberine exerts protective effects on cardiac senescence by regulating the Klotho/SIRT1 signaling pathway.
Li C; Jiang S; Wang H; Wang Y; Han Y; Jiang J
Biomed Pharmacother; 2022 Jul; 151():113097. PubMed ID: 35609366
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine potentiates the hypoglycemic efficacy of berberine by inhibiting P-glycoprotein function.
Shan YQ; Zhu YP; Pang J; Wang YX; Song DQ; Kong WJ; Jiang JD
Biol Pharm Bull; 2013; 36(10):1562-9. PubMed ID: 23924821
[TBL] [Abstract][Full Text] [Related]
19. Berberine ameliorates experimental diabetes-induced renal inflammation and fibronectin by inhibiting the activation of RhoA/ROCK signaling.
Xie X; Chang X; Chen L; Huang K; Huang J; Wang S; Shen X; Liu P; Huang H
Mol Cell Endocrinol; 2013 Dec; 381(1-2):56-65. PubMed ID: 23896433
[TBL] [Abstract][Full Text] [Related]
20. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells through a phosphatidylinositol 3-kinase/Akt-dependent mechanism.
Zhang X; Liang D; Lian X; Jiang Y; He H; Liang W; Zhao Y; Chi ZH
Apoptosis; 2016 Jun; 21(6):721-36. PubMed ID: 26979714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
